(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 9.68% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 8.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Cognex's revenue in 2026 is $994,359,000.On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $181,118,756,560, with the lowest CGNX revenue forecast at $170,513,449,680, and the highest CGNX revenue forecast at $192,718,310,960. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $197,026,716,880, with the lowest CGNX revenue forecast at $175,816,103,120, and the highest CGNX revenue forecast at $216,745,959,360.
In 2028, CGNX is forecast to generate $219,397,286,080 in revenue, with the lowest revenue forecast at $202,163,662,400 and the highest revenue forecast at $242,762,102,800.